Intuitive’s shares fall 8% after tempering 2026 procedural growth outlook
The robotic surgery giant now expects procedural growth to fall at the 14% to 15% midpoint for 2026, versus between 13.5% and 15.5% previously.
The robotic surgery giant now expects procedural growth to fall at the 14% to 15% midpoint for 2026, versus between 13.5% and 15.5% previously.
The British government will now change up AI-enabled medical device regulation to encourage innovation with the appropriate guardrails.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme